SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3/A - Registration statement under Securities Act of 1933: [Amend]
SEC Accession No. 0001654954-24-003884
Filing Date
2024-03-28
Accepted
2024-03-28 17:14:00
Documents
8

Document Format Files

Seq Description Document Type Size
1 FORM S-3/A ndra_s3a.htm S-3/A 598708
2 CONSULTING SERVICES AGREEMENT ndra_ex49.htm EX-4.9 80828
3 RESTRICTED STOCK AGREEMENT ndra_ex410.htm EX-4.10 36995
4 CONSENT LETTER ndra_ex231.htm EX-23.1 1522
5 ndra_ex49img1.jpg GRAPHIC 4542
6 ndra_s3aimg12.jpg GRAPHIC 6066
7 ndra_s3aimg14.jpg GRAPHIC 11710
8 ndra_s3img2.jpg GRAPHIC 56427
  Complete submission text file 0001654954-24-003884.txt   828155
Mailing Address 3600 GREEN COURT SUITE 350 ANN ARBOR MI 48105
Business Address 3600 GREEN COURT SUITE 350 ANN ARBOR MI 48105 734-335-0468
ENDRA Life Sciences Inc. (Filer) CIK: 0001681682 (see all company filings)

IRS No.: 260579295 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3/A | Act: 33 | File No.: 333-277058 | Film No.: 24800337
SIC: 3845 Electromedical & Electrotherapeutic Apparatus
(CF Office: 08 Industrial Applications and Services)